Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi(University of Kurdistan), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Fatemeh Karimian Noukabadi(Islamic Azad University, Isfahan), Vahid Karpisheh(Tabriz University of Medical Sciences), Farbod Ebrahimi(North Carolina Agricultural and Technical State University), Negin Afsharimanesh(Islamic Azad University of Hamedan), Naime Majidi Zolbanin(Urmia University), Seyed Hossein Kiaie(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Fariba Karoon Kiani(Tabriz University of Medical Sciences), Reza Jafari(Urmia University), Hadi Hassannia(Mazandaran University of Medical Sciences), Sanam Nami(Tabriz University of Medical Sciences), Ata Mahmoodpoor(Tabriz University of Medical Sciences), Pooya Jalali(Tabriz University of Medical Sciences)
Cited by 3
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
|Molecular Immunology|2018|194